# Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes

> **NCT01322711** · PHASE4 · UNKNOWN · sponsor: **University of Roma La Sapienza** · enrollment: 60 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus
- Hypercholesterolemia

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01322711
- **Lead sponsor:** University of Roma La Sapienza
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-03
- **Primary completion:** 2015-10
- **Final completion:** 2015-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2015-05-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01322711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01322711, "Atorvastatin, Aspirin, Oxidative Stress, Coagulation and Platelet Activation Indexes". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01322711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*